Filter Results:
(1,676)
Show Results For
- All HBS Web
(1,676)
- People (4)
- News (506)
- Research (918)
- Events (5)
- Multimedia (22)
- Faculty Publications (487)
Show Results For
- All HBS Web
(1,676)
- People (4)
- News (506)
- Research (918)
- Events (5)
- Multimedia (22)
- Faculty Publications (487)
Toren Fronsdal
Toren Fronsdal is a doctoral student in the Business Economics program. His research interests are industrial organization and health economics, primarily focusing on hospital and insurer negotiations. He graduated from Stanford University with a B.A. in Economics in... View Details
- December 12, 2023
- Article
Prices for Common Services at Quaternary vs Nonquaternary Hospitals
By: Brandon W. Yan, Maximilian J. Pany and Leemore S. Dafny
Using commercial health insurance claims data from 2017-2019, we assessed whether quaternary hospitals charged higher prices for common, unspecialized services also offered by nonquaternary hospitals. We found quaternary-hospital price premiums of 8.2 percent, on... View Details
Yan, Brandon W., Maximilian J. Pany, and Leemore S. Dafny. "Prices for Common Services at Quaternary vs Nonquaternary Hospitals." JAMA, the Journal of the American Medical Association 330, no. 22 (December 12, 2023): 2211–2213.
- February 2015 (Revised November 2015)
- Case
Building an Integrated Biopharma Company: Crucell (A)
By: Richard G. Hamermesh, Marianne Van Der Steen and Susan S. Harmeling
By 2009, Crucell had become the largest biopharma company in the Netherlands and a symbol of national pride. The case traces the evolution of the company from a University spin-off into a fully-integrated company. Crucell's success, particularly in the vaccine space,... View Details
Keywords: Biotechnology; Biopharmacy Company; Licensing; Licensing Agreements In Biopharmacy; Human Cell-line Technology; Vaccine; Healthcare Innovation; Global Health; Partners and Partnerships; Entrepreneurship; Growth and Development Strategy; Biotechnology Industry; Pharmaceutical Industry; Netherlands
Hamermesh, Richard G., Marianne Van Der Steen, and Susan S. Harmeling. "Building an Integrated Biopharma Company: Crucell (A)." Harvard Business School Case 815-085, February 2015. (Revised November 2015.)
- 25 Nov 2016
- News
A change called NeHA
- Article
The Economic Consequences of Hospital Admissions
By: Carlos Dobkin, Amy Finkelstein, Raymond Kluender and Matthew Notowidigdo
We use an event study approach to examine the economic consequences of hospital admissions for adults in two datasets: survey data from the Health and Retirement Study, and hospitalization data linked to credit reports. For non-elderly adults with health insurance,... View Details
Keywords: Personal Finance; Borrowing and Debt; Insurance; Insolvency and Bankruptcy; Health Care and Treatment
Dobkin, Carlos, Amy Finkelstein, Raymond Kluender, and Matthew Notowidigdo. "The Economic Consequences of Hospital Admissions." American Economic Review 108, no. 2 (February 2018): 308–352.
- October 2022 (Revised August 2024)
- Case
Cigna-Express Scripts: Can a Vertical Merger Rescue an Industry Under Attack?
By: Leemore Dafny
In Fall 2019, Cigna Corporation – a global health services company with a significant presence in the U.S. employer-sponsored health insurance market - was digesting its $54 billion acquisition of Express Scripts, Inc. (ESI), a pharmacy benefit manager (PBM)... View Details
Dafny, Leemore. "Cigna-Express Scripts: Can a Vertical Merger Rescue an Industry Under Attack?" Harvard Business School Case 323-038, October 2022. (Revised August 2024.)
- 29 Oct 2014
- News
The Businessman Disrupting Organ Transplantation
- 31 Jul 2018
- First Look
New Research and Ideas, July 31, 2018
Shankar MD, Suptendra N. Sarbadhikari PhD, Barbara Bierer, Kenneth D. Mandl MD, Sanjay Mehendale MD, MPH, and Tarun Khanna Abstract—In February 2018, the Government of India announced a massive public health View Details
Keywords: Dina Gerdeman
- 27 Aug 2013
- First Look
First Look: August 27
https://www.hbs.edu/faculty/Pages/item.aspx?num=45271 August 2013 Journal of Health Economics Consumers' Misunderstanding of Health Insurance By: Loewenstein, George, Joelle Y.... View Details
Keywords: Sean Silverthorne
- 11 Mar 2020
- News
May I Take Your Order?
- December 1994 (Revised October 1996)
- Case
Byrnes, Byrnes & Townsend: Case and Simulation
Designed to be used in conjunction with Patriot National Insurance Co. Discusses a suit brought by a woman client who was badly injured in an automobile accident and alleges that a proximate cause of the accident was faulty repairs on her car by a Patriot-insured auto... View Details
Hammond, John S., and Marjorie Corman Aaron. "Byrnes, Byrnes & Townsend: Case and Simulation." Harvard Business School Case 395-135, December 1994. (Revised October 1996.)
- 2019
- Chapter
Behavioral Economics and Health-Care Markets
By: Amitabh Chandra, Benjamin Handel and Joshua Schwartzstein
This chapter summarizes research in behavioral health economics, focusing on insurance markets and product markets in health care. We argue that the prevalence of choice difficulties and biases leading to mistakes in these markets establish a special place for them in... View Details
Keywords: Behavioral Economics; Consumer Behavior; Economics; Health Care and Treatment; Insurance; Markets
Chandra, Amitabh, Benjamin Handel, and Joshua Schwartzstein. "Behavioral Economics and Health-Care Markets." Chap. 6 in Handbook of Behavioral Economics: Foundations and Applications 2, edited by B. Douglas Bernheim, Stefano DellaVigna, and David Laibson, 459–502. Amsterdam: Elsevier/North-Holland, 2019.
- 14 Jul 2006
- News
The Case for Consumer-Driven Medicaid
- 10 Jun 2021
- News
Preparing Hospitals for the Next Pandemic
- Research Summary
Behavioral Hazard and Public Policy
It is well recognized that people overuse low-value medical care due to moral hazard—because copays are lower than costs. Now Professor Schwartzstein has introduced the concept of “behavioral hazard” to explain the opposite: people underuse high-value care because... View Details
- 05 Jun 2012
- First Look
First Look: June 5
bond market. Specifically, we show evidence for reaching for yield among insurance companies, the largest institutional holders of corporate bonds. Insurance companies have capital requirements tied to the... View Details
Keywords: Sean Silverthorne
- June 2005 (Revised August 2011)
- Case
Narayana Hrudayalaya Heart Hospital: Cardiac Care for the Poor (A)
By: Tarun Khanna, V. Kasturi Rangan and Merlina Manocaran
Describes the mission, vision, and strategy of a team of entrepreneurs headed by a charismatic heart surgeon who founded a heart hospital in Bangalore, India. The purpose of the hospital was to offer health care for the masses. This tertiary care hospital performed... View Details
Keywords: Social Entrepreneurship; Health Care and Treatment; Goals and Objectives; Social Marketing; Mission and Purpose; Strategic Planning; Social Enterprise; Welfare; Health Industry; Health Industry; Bangalore
Khanna, Tarun, V. Kasturi Rangan, and Merlina Manocaran. "Narayana Hrudayalaya Heart Hospital: Cardiac Care for the Poor (A)." Harvard Business School Case 505-078, June 2005. (Revised August 2011.)
- June 2014 (Revised September 2014)
- Case
Johnson & Johnson: The Promotion of Wellness
By: John A. Quelch and Carin-Isabel Knoop
To create the world's healthiest workforce, diversified health care giant Johnson & Johnson (J&J) mandated participation in its "Culture of Health" program globally, customized by location, culture, and specific health needs to offer prevention-focused education,... View Details
Keywords: Healthcare; Employee Motivation; Transformation; Ethics; Health; Human Resources; Leadership; Management; Personal Development and Career; Problems and Challenges; Strategy; Health Industry; Health Industry; Health Industry; North and Central America; Middle East; Latin America; Europe; Asia
Quelch, John A., and Carin-Isabel Knoop. "Johnson & Johnson: The Promotion of Wellness." Harvard Business School Case 514-112, June 2014. (Revised September 2014.)